TC Biopharm (Holdings) Plc

TCBP

5 Followers
$0.50 +0.00% $0.00
N/A
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

TC Biopharm (Holdings) Plc (TCB) is a biotechnology company focused on the development and production of T cell-based immunotherapies for the treatment of cancer and viral infections. Their innovative approach involves using genetically modified T cells to combat diseases. TCB is dedicated to research and clinical trials aimed at providing patients with new and effective therapeutic options. Shares of TC Biopharm (Holdings) Plc (TCB) could be an attractive choice for investors seeking investment opportunities in the biotechnology sector with an emphasis on novel therapies for cancer and viral infections.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade